Clinical Trial Update: A Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease [Phase 3]

View source ↗

Summary

The document reports that a Phase 3 trial evaluating an Aldeyra Therapeutics investigational therapy for Dry Eye Disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Aldeyra Therapeutics investigational therapy

Snippet

Sponsor: Aldeyra Therapeutics, Inc. | Conditions: Dry Eye Disease | Phase 3 | Status: COMPLETED